Fibrosis-Inflammation Lab

⌘K

Fibrosis-Inflammation Lab

Accelerating fibrosis and inflammation research through validated preclinical models and expert insights.

Research

Models
Drugs
Insights
Resources
Pathways

Company

About
Contact Us
Privacy Policy

© 2026 Fibrosis-Inflammation Lab. All rights reserved.

/

/

Tanzisertib (tanzisertib) | Accelerate Your Fibrosis Research

Home/Drugs/Tanzisertib

Tanzisertib

tanzisertib

Phase 2a

Sponsor: Celgene

Indication: IPF

Mechanism of Action

JNK inhibitor

Target: JNK

Clinical Information

Approval Year

Clinical Trials (ClinicalTrials.gov)

No clinical trials found for tanzisertib.

Relevant Publications (PubMed)

No recent publications found for tanzisertib.

Validated Models

This drug has been validated in the following preclinical models: